RAYMOND JAMES & ASSOCIATES - INVIVO THERAPEUTICS HLDGS CO ownership

INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 51 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q1 2018$40,000
-34.4%
74,000
-6.8%
0.00%
Q4 2017$61,000
-51.6%
79,400
-8.6%
0.00%
Q3 2017$126,000
-9.4%
86,833
+68.8%
0.00%
Q2 2017$139,000
-69.8%
51,433
-54.8%
0.00%
-100.0%
Q1 2017$461,000
+34.0%
113,749
+38.9%
0.00%0.0%
Q4 2016$344,000
-24.6%
81,888
+22.2%
0.00%0.0%
Q3 2016$456,000
+162.1%
67,013
+122.9%
0.00%0.0%
Q2 2016$174,000
-5.4%
30,058
+13.8%
0.00%0.0%
Q1 2016$184,00026,4080.00%
Other shareholders
INVIVO THERAPEUTICS HLDGS CO shareholders Q2 2017
NameSharesValueWeighting ↓
IMS Capital Management 391,149$1,056,0001.00%
ELEMENT CAPITAL MANAGEMENT LLC 136,192$368,0000.08%
WELCH & FORBES LLC 400,614$1,081,0000.03%
Indiana Trust & Investment Management CO 19,250$52,0000.03%
FLAGSHIP HARBOR ADVISORS, LLC 15,415$34,0000.01%
LMR Partners LLP 58,775$159,0000.01%
BOSTON FINANCIAL MANGEMENT LLC 49,175$133,0000.01%
HYMAN CHARLES D 30,000$81,0000.01%
Baker Brothers Advisors 400,000$1,080,0000.01%
OneDigital Investment Advisors LLC 8,911$24,0000.01%
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders